Next Generation News and Research

RSS

Unlocking intrinsically disordered proteins: an interview with Peter Wright

I'm a professor in the Department of Integrative Structural and Computational Biology at The Scripps Research Institute. I have been performing NMR research on proteins for nearly 40 years.

From Bruker BioSpin Group 11 Feb 2016

Landauer's revenues decrease 2.7% to $36.5 million in first fiscal quarter of 2016

Landauer, Inc., a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, today reported financial results for its fiscal 2016 first quarter ended December 31, 2015.

9 Feb 2016

New personalized DNA-based digital assay has potential to dramatically impact CML management

The outcomes of chronic myeloid leukemia (CML) have dramatically improved as the result of tyrosine kinase inhibitor (TKI) treatment. Use of a TKI regimen can lower the blood CML biomarker to levels imperceptible by current detection methods. For patients in "molecular remission," however, uncertainties remain regarding whether they will relapse or if treatment should be discontinued.

8 Feb 2016

PTC showcases Vuforia, ThingWorx and new ThingX technology during ThingEvent broadcast

The largest IOT-focused audience ever assembled joined PTC in taking ‘a fresh look at things’ during its recent ThingEvent™ broadcast, where the company showcased Vuforia, ThingWorx, and new ThingX™ technology to demonstrate how augmented reality can change the way companies create, operate and service smart, connected things.

4 Feb 2016

New UEA-led research initiative aims to improve understanding of deictic communication in humans

A major new €3.5 million research initiative led by the University of East Anglia will aim to improve understanding of a fundamental part of communication in humans.

1 Feb 2016

VARI-SU2C Epigenetics Dream Team supports new clinical trial that targets metastatic colorectal cancer

The first clinical trial to move forward as part of the Van Andel Research Institute-Stand Up To Cancer (VARI-SU2C) Epigenetics Dream Team will target metastatic colorectal cancer, the second leading cause of cancer deaths among men and women combined in the U.S.

29 Jan 2016

New breakthrough drug shows promise to fight antibiotic-resistant infections

A New York pharmaceutical company, TGV-Laboratories, has developed a groundbreaking drug that shows promise in treating a wide variety of antibiotic-resistant fungal and bacterial infections.

28 Jan 2016

CosmosID announces $6M in Series B funding round

CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-generation DNA sequencing, announced $6M in Series B funding.

28 Jan 2016

Panasonic introduces new -40°C freezer with hydrocarbon refrigerant

New MDF-U5412H -40°C Freezers from Panasonic, with hydrocarbon refrigerants for increased efficiency, provide the ideal stable and uniform storage environment for the preservation of plasma

From PHC Europe B.V. 26 Jan 2016

Researchers identify three single-driver genetic alterations that occur in neuroepithelial tumors

The St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project (PCGP) has identified critical driver genes that account for disease-related alterations in a range of uncommon low-grade neuroepithelial tumors.

26 Jan 2016

Biomedical innovation in the UK: an interview with Zahid Latif

The biomedical research base is one of the UK's strengths; over 1500 companies in the Pharmaceuticals and biotechnology area are established in the UK employing over 70,000.

22 Jan 2016

Beckman Coulter Access Family of Immunoassay Systems release new access TSH (3rd IS) Assay

Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company’s Access Family of Immunoassay Systems.

From Beckman Coulter Diagnostics 22 Jan 2016

Paradigm, UnitedHealthcare sign contractual agreement for coverage of PCDx

Paradigm, a molecular information & Next Generation Sequencing corporation specializing in providing testing for cancer patients today announced that it has entered into a contractual agreement with UnitedHealthcare for coverage of PCDx.

21 Jan 2016

CSU's BioMARC awarded DoD contract to help develop new vaccines to combat encephalitic viruses

Colorado State University's Biopharmaceutical Manufacturing and Academic Resource Center has been awarded a 10-month, $4.6 million contract funded by the Department of Defense to help develop and manufacture new vaccines to fight encephalitic viruses that cause inflammation of the brain.

21 Jan 2016

UC Berkeley researchers make major improvement in CRISPR-Cas9 gene editing technology

University of California, Berkeley, researchers have made a major improvement in CRISPR-Cas9 technology that achieves an unprecedented success rate of 60 percent when replacing a short stretch of DNA with another.

21 Jan 2016

Antivirulence antibiotics could evade resistance longer than traditional antibiotics

We've all seen the headlines. "Man found to be shedding virulent strain of polio"; "Virulent flu strain in Europe hits the economy"; "Most virulent strain of E. coli ever seen contains DNA sequences from plague bacteria."

19 Jan 2016

Scientists find new way to re-engineer body’s immune system to target cancer

Scientists have demonstrated a new way of re-engineering the body’s immune system to target cancer, paving the way for a new generation of drugs, unprecedented in safety and effectiveness.

18 Jan 2016

Loyola Physician Partners selected to participate in CMS' NGACO Model

Loyola Physician Partners, as a member of Trinity Health and the Trinity Health ACO, has been selected to participate in the Centers for Medicare & Medicaid Services's Next Generation ACO Model (NGACO Model).

13 Jan 2016

New gene-filtering tool aims to predict disease-causing mutations

Despite their bad reputations, the vast majority of mutations are not harmful. Even in very rare genetic disorders, only one or two genetic variations — out of tens of thousands — is actually the cause of disease. Distinguishing between harmful and harmless mutations has long been a challenge.

13 Jan 2016

Genomics portfolio expanded by Illumina

Illumina, Inc., the global leader in sequencing and array-based technologies, today announced the newest addition to its industry-leading next-generation sequencing (NGS) portfolio with the launch of the MiniSeq Sequencing System.

From Illumina, Inc. 12 Jan 2016

Next Generation News and Research

Unlocking intrinsically disordered proteins: an interview with Peter Wright

Landauer's revenues decrease 2.7% to $36.5 million in first fiscal quarter of 2016

New personalized DNA-based digital assay has potential to dramatically impact CML management

PTC showcases Vuforia, ThingWorx and new ThingX technology during ThingEvent broadcast

New UEA-led research initiative aims to improve understanding of deictic communication in humans

VARI-SU2C Epigenetics Dream Team supports new clinical trial that targets metastatic colorectal cancer

New breakthrough drug shows promise to fight antibiotic-resistant infections

CosmosID announces $6M in Series B funding round

Panasonic introduces new -40°C freezer with hydrocarbon refrigerant

Researchers identify three single-driver genetic alterations that occur in neuroepithelial tumors

Biomedical innovation in the UK: an interview with Zahid Latif

Beckman Coulter Access Family of Immunoassay Systems release new access TSH (3rd IS) Assay

Paradigm, UnitedHealthcare sign contractual agreement for coverage of PCDx

CSU's BioMARC awarded DoD contract to help develop new vaccines to combat encephalitic viruses

UC Berkeley researchers make major improvement in CRISPR-Cas9 gene editing technology

Antivirulence antibiotics could evade resistance longer than traditional antibiotics

Scientists find new way to re-engineer body’s immune system to target cancer

Loyola Physician Partners selected to participate in CMS' NGACO Model

New gene-filtering tool aims to predict disease-causing mutations

Genomics portfolio expanded by Illumina

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News